GUARDANT HEALTH INC (GH)
US40131M1099 - Common Stock
GH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 107 industry peers in the Health Care Providers & Services industry. The financial health of GH is average, but there are quite some concerns on its profitability. GH is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
In the past year GH has reported negative net income.
In the past year GH has reported a negative cash flow from operations.
GH had negative earnings in each of the past 5 years.
In the past 5 years GH always reported negative operating cash flow.
1.2 Ratios
GH has a Return On Assets of -33.30%. This is amonst the worse of the industry: GH underperforms 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -33.3% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-28.63%
ROA(5y)-20.99%
ROE(3y)-484.14%
ROE(5y)-296.29%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of GH (60.31%) is better than 82.86% of its industry peers.
In the last couple of years the Gross Margin of GH has grown nicely.
GH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 60.31% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.1%
GM growth 5Y2.69%
2. Health
2.1 Basic Checks
GH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GH has been increased compared to 1 year ago.
The number of shares outstanding for GH has been increased compared to 5 years ago.
The debt/assets ratio for GH has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -0.53, we must say that GH is in the distress zone and has some risk of bankruptcy.
GH has a worse Altman-Z score (-0.53) than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.53 |
ROIC/WACCN/A
WACC8.16%
2.3 Liquidity
GH has a Current Ratio of 6.22. This indicates that GH is financially healthy and has no problem in meeting its short term obligations.
GH has a better Current ratio (6.22) than 96.19% of its industry peers.
GH has a Quick Ratio of 5.85. This indicates that GH is financially healthy and has no problem in meeting its short term obligations.
GH has a better Quick ratio (5.85) than 96.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.22 | ||
| Quick Ratio | 5.85 |
3. Growth
3.1 Past
GH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.55%, which is quite good.
The Revenue has grown by 29.20% in the past year. This is a very strong growth!
GH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 44.15% yearly.
EPS 1Y (TTM)13.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.55%
Revenue 1Y (TTM)29.2%
Revenue growth 3Y25.3%
Revenue growth 5Y44.15%
Sales Q2Q%33.87%
3.2 Future
The Earnings Per Share is expected to grow by 14.20% on average over the next years. This is quite good.
Based on estimates for the next years, GH will show a very strong growth in Revenue. The Revenue will grow by 21.22% on average per year.
EPS Next Y0.44%
EPS Next 2Y7.26%
EPS Next 3Y9.73%
EPS Next 5Y14.2%
Revenue Next Year29.78%
Revenue Next 2Y23.17%
Revenue Next 3Y22.3%
Revenue Next 5Y21.22%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for GH. In the last year negative earnings were reported.
Also next year GH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.26%
EPS Next 3Y9.73%
5. Dividend
5.1 Amount
GH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
GUARDANT HEALTH INC
NASDAQ:GH (1/6/2025, 8:00:01 PM)
After market: 36.99 +1.11 (+3.09%)35.88
+2.12 (+6.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners99.2%
Inst Owner Change0%
Ins Owners4.53%
Ins Owner Change0.72%
Market Cap4.43B
Analysts85.81
Price Target42.64 (18.84%)
Short Float %7%
Short Ratio4.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.28%
Min EPS beat(2)-14.73%
Max EPS beat(2)-9.83%
EPS beat(4)1
Avg EPS beat(4)-6.79%
Min EPS beat(4)-14.73%
Max EPS beat(4)4.53%
EPS beat(8)5
Avg EPS beat(8)5.97%
EPS beat(12)7
Avg EPS beat(12)4.92%
EPS beat(16)7
Avg EPS beat(16)-2.27%
Revenue beat(2)2
Avg Revenue beat(2)7.36%
Min Revenue beat(2)5.76%
Max Revenue beat(2)8.95%
Revenue beat(4)4
Avg Revenue beat(4)5.98%
Min Revenue beat(4)0.65%
Max Revenue beat(4)8.95%
Revenue beat(8)7
Avg Revenue beat(8)4.15%
Revenue beat(12)9
Avg Revenue beat(12)2.9%
Revenue beat(16)11
Avg Revenue beat(16)2.69%
PT rev (1m)0.48%
PT rev (3m)1.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.66%
EPS NY rev (1m)-3.25%
EPS NY rev (3m)-6.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 6.4 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-3.51
EYN/A
EPS(NY)-3.02
Fwd EYN/A
FCF(TTM)-2.22
FCFYN/A
OCF(TTM)-2.06
OCFYN/A
SpS5.6
BVpS-0.49
TBVpS-0.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -33.3% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 60.31% | ||
| FCFM | N/A |
ROA(3y)-28.63%
ROA(5y)-20.99%
ROE(3y)-484.14%
ROE(5y)-296.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.1%
GM growth 5Y2.69%
F-Score3
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 47.39% | ||
| Cap/Sales | 2.93% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 6.22 | ||
| Quick Ratio | 5.85 | ||
| Altman-Z | -0.53 |
F-Score3
WACC8.16%
ROIC/WACCN/A
Cap/Depr(3y)200.05%
Cap/Depr(5y)224.5%
Cap/Sales(3y)13.65%
Cap/Sales(5y)13.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.55%
EPS Next Y0.44%
EPS Next 2Y7.26%
EPS Next 3Y9.73%
EPS Next 5Y14.2%
Revenue 1Y (TTM)29.2%
Revenue growth 3Y25.3%
Revenue growth 5Y44.15%
Sales Q2Q%33.87%
Revenue Next Year29.78%
Revenue Next 2Y23.17%
Revenue Next 3Y22.3%
Revenue Next 5Y21.22%
EBIT growth 1Y-0.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year47.41%
EBIT Next 3Y17.98%
EBIT Next 5Y16.14%
FCF growth 1Y29.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.08%
OCF growth 3YN/A
OCF growth 5YN/A